Histopathological spectrum of papillary carcinoma thyroid – a 4 year retrospective analysis
Abstract
Introduction: Papillary carcinoma of thyroid is the most common malignant tumor constituting about 80% of all malignancies of thyroid. It has an indolent course with an excellent prognosis and numerous histological variants have been reported till date. Also various associated lesions are also being noted, of which has himotos thyroiditis is one of the common lesions.
Objective: 1) To analyse various histopathological features of papillary carcinoma thyroid. 2) To evaluate the presence or absence of has himotos thyroiditis in the background of papillary carcinoma.
Design: Hospital based cross sectional study. Subject: Histopathologically diagnosed cases of papillary carcinoma thyroid in a 4 year period.
Methods: Retrospective analysis of histopathologically diagnosed cases of papillary carcinoma thyroidhas been done. Results: Papillary carcinoma thyroid is more prevalent among females with most of the lesions showing conventional papillary pattern in 72.8% cases. Almost all the cases have the typical nuclear features described. Hashimotos thyroiditis is seen in 44.2% of the cases. Papillary micro carcinoma seen in 17.1% patients. Multi focality is seen in 28.5%. The association between papillary carcinoma and has himotos thyroiditis was evaluated using chi square test, p value= 0.001 and was found to be statistically significant.
Conclusion: Our study has well correlated with the literature, with regards to epidemiological profile and the predominant histopathological pattern. Hashimotos thyroiditis is predominant associated lesion.
Downloads
References
2. Baloch ZW, LiVolsi VA. Neuroendocrine tumors of the thyroid gland. Am J Clin Pathol. 2001 Jun;115 Suppl:S56-67.
3. Katoh R, Sasaki J, Kurihara H, Suzuki K, Iida Y, Kawaoi A.Multiplethyroidinvolvement (intraglandularmetastasis) in papillary thyroid carcinoma. A clinicopathologicstudy of 105consecutivepatients. Cancer. 1992 Sep 15;70(6):1585-90. [PubMed]
4. Singh B, Shaha AR, Trivedi H, Carew JF, Poluri A, Shah JP.CoexistentHashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome.Surgery. 1999 Dec;126(6):1070-6; discussion 1076-7. [PubMed]
5. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.
6. Gangadharan P, Nair MK, Pradeep VM. Thyroid Cancer in Kerala. In: Shah AH, Samuel AM, Rao RS. Thyroid Cancer- An Indian Perspective. Mumbai: Quest Publications;1999;17–32.
7. Sakoda LC, Horn-Ross, PL. Reproductive and Menstrual History and Papillary Thyroid Cancer Risk The San Francisco Bay Area Thyroid Cancer Study. Cancer Epidemiology Biomarkers & Prevention.2002;11:51-57.
8. Hunt JL. Radiation induced thyroid diseases. Pathology Case Rev.2009;14:224–230.
9. Johannessen JV, Sobrinho-Simões M. The origin and significance of thyroid psammoma bodies. Lab Invest. 1980 Sep;43(3):287-96.
10. Hunt JL, Barnes EL. Non-tumor-associated psammoma bodies in the thyroid. Am J Clin Pathol. 2003 Jan;119(1):90-4. [PubMed]
11. Das DK.Psammomabody: a product of dystrophiccalcification or of a biologicallyactiveprocess that aims at limiting the growth and spread of tumor? Diagn Cytopathol. 2009 Jul;37(7):534-41. doi: 10.1002/dc.21081.
12. Rosai J, Tallini G. Thyroid gland. In: Rosai J editor. Rosai and Ackerman’s surgical pathology. 10th ed. New York: Mosby Elsevier. 2011:487-564.
13. Roti E, degliUberti EC, Bondanelli M, Braverman LE. Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eur J Endocrinol. 2008;159(6):659-73. [PubMed]
14. Li F, Chen G, Sheng C, Gusdon AM, Huang Y, Lv Z, Xu H, Xing M, Qu S. BRAFV600E mutation in papillary thyroid microcarcinoma: A meta-analysis. EndocrRelat Cancer. 2015 Apr;22(2):159-68. doi: 10.1530/ERC-14-0531. Epub 2015 Jan 15. [PubMed]
15. Rosai J, LiVolsi VA, Sobrinho-Simoes M, Williams ED. Renaming papillary microcarcinoma of the thyroid gland: the Porto proposal. Int J SurgPathol. 2003 Oct;11(4):249-51.
16. Katoh R, Sasaki J, Kurihara H, Suzuki K, Iida Y, Kawaoi A. Multiple thyroid involvement (intraglandular metastasis) in papillary thyroid carcinoma: A clinicopathologic study of 105 consecutive patients. Cancer. 1992 Sep 15;70(6):1585-90.
17. Giannini R, Ugolini C, Lupi C, et al. The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma. J Clin Endocrinol Metab.2007; 92: 3511-6. [PubMed]
18. Shattuck TM, Westra WH, Ladenson PW, Arnold A. Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma. N Engl J Med. 2005 Jun 9;352(23):2406-12.
19. Dailey ME, Lindsay S, Skahen R. Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. Arch Surg. 1955;70(2): 291–297. [PubMed]
20. Okayasu I, Fujiwara M, Hara Y, Tanaka Y, Rose NR. Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans. Cancer 1995;76:2312–2318. [PubMed]
21. Fiore E et al (2011) Hashimoto’s thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with Lthyroxine. EndocrRelat Cancer. 2011 Jul 1;18(4):429-37. doi: 10.1530/ERC-11-002. Print 2011 Aug. [PubMed]
22. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002 Dec 19-26;420(6917):860-7.
23. Kang DY, Kim KH, Kim JM et al. High prevalence of RET, RAS, and ERK expression in Hashimoto’s thyroiditis and in papillary thyroid carcinoma in the Korean population. Thyroid.2007;17(11): 1031–1038. [PubMed]
24. Colotta F, Allavena P, Sica A et al. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009 Jul;30(7):1073-81. doi: 10.1093/carcin/bgp127. Epub 2009 May 25. [PubMed]
25. Crawford S, Belajic D, Wei J et al. A novel B-RAF inhibitor blocks interleukin-8 (IL-8) synthesis in human melanoma xenografts revealing IL-8 as a potential pharmacodynamics biomarker. Mol Cancer Ther. 2008;7(3):492–499.
OAI - Open Archives Initiative
